Literature DB >> 19762576

Clinical features of patients with typhoid fever and drug resistance of the causative isolates in western Iran.

Ranjbar Mitra1, Mohammad Alizadeh Amir Houshang, Hashemi Seyed Hamid, Dadashpoor Maryam, Madrakian Ali Reza, Hadidchi Shima, Nojomi Marzieh.   

Abstract

Typhoid fever is an important infectious disease in developing countries, including Iran. In this survey, all patients hospitalized in teaching hospitals of Hamedan during 1995-2005 were investigated. A total of 162 patients with typhoid fever were studied. Of all patients, 106 were male (65.4%). The most prevalent symptoms were fever (93.2%), chills (76.5%), anorexia (72.2%) and headache (71%). Splenomegaly and hepatomegaly were present in 43.8% and 13.6%, respectively. Salmonella typhi strains were identified in 144 patients (88.9%) and S. paratyphi A strains were found in 12 (7.4%). In others, S. paratyphi B and C were detected. Serum glutamic oxalo-acetic transaminase values were higher than normal in 77.5% of cases and serum glutamic pyruvic transaminase values were higher than normal in 62.5%. The highest sensitivity rate was for ceftizoxime, 91.4% and the lowest rate was for ampicillin, 16.3%.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19762576     DOI: 10.1258/td.2009.090046

Source DB:  PubMed          Journal:  Trop Doct        ISSN: 0049-4755            Impact factor:   0.731


  3 in total

1.  Analysis of characteristics of paratyphoid A in 157 Chinese inpatients between 1998 and 2009.

Authors:  F Yu; S Fan; X Fan; P Dong; X Wang; Y Chen; J Li
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-09-09       Impact factor: 3.267

2.  Epidemiology of Typhoid Fever in Iran during Last Five Decades from 1962-2011.

Authors:  Hossein Masoumi Asl; Mohammad Mehdi Gouya; Mahmood Nabavi; Nooshin Aghili
Journal:  Iran J Public Health       Date:  2013-01-01       Impact factor: 1.429

3.  Typhoid fever among febrile Nigerian patients: Prevalence, diagnostic performance of the Widal test and antibiotic multi-drug resistance.

Authors:  Martin E Ohanu; Michael O Iroezindu; Uzoamaka Maduakor; Obinna D Onodugo; Harish C Gugnani
Journal:  Malawi Med J       Date:  2019-09       Impact factor: 0.875

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.